Company / SG&A Expense
Annexon, Inc. SG&A Expense History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$34.6M
FY2024
5-year range
$14.2M / $34.6M
FY2020-FY2024
Trend
+15.5%
vs FY2023
Sector context
#174 of 211
Health Care
What the data says
Annexon, Inc.'s sg&a expense of $35M is lower than 82% of companies in the Health Care sector (FY2024). Increased from $33M to $35M over the past 2 years.
Based on SEC 10-K filings.
$35M in FY2024 with a 5-year CAGR of +34.1%.
Increased from $33M to $35M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +4.2%
- 5-Year CAGR
- +34.1%
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 211This company $34.6M Sector average $728.7M
▼
-95.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +34.1%, indicating consistent growth.
- In FY2024, sg&a expense increased 15.5% year-over-year.
- Ranks #174 out of 211 companies in the Health Care sector.
- Lowest sg&a expense in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $34.6M | +15.5% |
| FY2023 | $30.0M | -9.5% |
| FY2022 | $33.1M | +8.0% |
| FY2021 | $30.6M | +115.9% |
| FY2020 | $14.2M | +77.6% |
| FY2019 | $8.0M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026